BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250408T130000
DTEND;TZID=America/New_York:20250408T140000
DTSTAMP:20260417T085252
CREATED:20250401T132103Z
LAST-MODIFIED:20250427T224018Z
UID:10000564-1744117200-1744120800@ctl.cornell.edu
SUMMARY:Lab to Impact: Medical Device Commercialization - A Journey from Breakthrough Research to Patient-Ready Technology
DESCRIPTION:Check out the recording for this event here. \nJoin the Center for Technology Licensing for a virtual session focused on medical device innovation and regulation.   \nBringing groundbreaking medical devices from concept to patient care is no small feat. It requires a careful balance of scientific ingenuity\, strategic development\, and regulatory compliance. Join us for an exclusive panel discussion featuring top experts who have successfully navigated this complex landscape.   \nThis session will provide invaluable insights into the journey from idea to market-ready medical technology\, covering key aspects such as:  \n\nNavigating the FDA approval process \n\n\nBalancing innovation with regulatory requirements \n\n\nStrategies for successful device development \n\n\nEmerging challenges in the medical device industry  \n\nWhether you’re considering a new idea\, commercialization\, or actively developing medical device solutions\, this panel offers valuable perspectives on turning promising research into market-ready medical devices.  \nMeet the expert panelists:  \n\nMark Melkerson – Former FDA Deputy Director\, Office of Health Technology / CDRH / ODE; Principal\, MNM Consulting \n\n\nThomas Roueche – President & CEO\, Fesarius Therapeutics \n\n\nJason Spector\, MD – Chief\, Division of Plastic & Reconstructive Surgery\, Weill Cornell Medicine; Co-Founder\, Fesarius Therapeutics \n\n 
URL:https://ctl.cornell.edu/event/lab-to-impact-medical-device-commercialization-a-journey-from-breakthrough-research-to-patient-ready-technology
CATEGORIES:CTL Events
END:VEVENT
END:VCALENDAR